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DNA pooling can provide an economic and eﬃcient way to detect susceptibility loci to complex diseases. We carried out a genome
screen with 400 microsatellite markers spaced at approximately 10cm in two DNA pools consisting of 119 schizophrenia (SZ)
patients and 119 controls recruited from a homogenous population in the Chang Le area of the Shandong peninsula of China.
Association of D6S289, a dinucleotide repeat polymorphism in the JARID2 gene with SZ, was found and conﬁrmed by individual
genotyping (X2 = 17.89; P = .047). In order to reﬁne the signal, we genotyped 14 single nucleotide polymorphisms (SNPs)
covering JARID2 and the neighboring gene, DNTBP1, in an extended sample of 309 cases and 309 controls from Shandong
peninsula (including the samples from the pools). However, rs2235258 and rs9654600 in JARID2 showed association in allelic,
genotypic and haplotypic tests with SZ patients from Chang Le area. This was not replicates in the extended sample, we conclude
that JARID2 could be a susceptibility gene for SZ.
Copyright © 2009 Yang Liu et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Schizophrenia, SZ (MIM 181500) is a severe psychiatric
disorder which aﬀects ∼1% of the general population and
has a strong genetic component [1]. However, the model
of transmission is complex and is most likely polygenic
[2]. Over the last two decades, linkage and association
studies have identiﬁed a number of chromosomal regions
and several promising candidate genes [3, 4]. Those for
which the evidence is the strongest are neuregulin 1
(NRG1),Dysbindin(DTNBP1),Disrupted-in-Schizophrenia
1( DISC1), and regulator of G-protein signalling 4 (RGS4).
In addition, D-amino oxidase activator (DAOA)h a sb e e n
implicated in multiple studies of schizophrenia and bipolar
disorder (BP) [5]. Support for the involvement of these
genes in the pathophysiology of psychotic disorders comes
from expression and neurobiological studies as well as from
linkage and association studies [6–9]. However, in spite of
what might appear an impressive weight of evidence, in
no case there has been consistent replication for the same
markers and haplotypes across studies, and speciﬁc risk or
protective nucleotide variants have not been consistently
andunambiguouslyidentiﬁed.Whilesuchconsistencymight
emerge as these genes are subjected to more detailed and
systematic analysis in suﬃciently large samples, the strength
and consistency of the genetic association evidence in
support of these candidates is not currently as strong as that
reported for other complex disorders such as type 1 and
2 diabetes, rheumatoid arthritis, and macular degeneration
[10–16].Muchhopeisnowpinnedontheresultsofgenome-
wide association (GWA) studies, as it is now possible to
conduct such studies with hundreds of thousands of SNPs.
However, such studies are expensive and require very large
sample sizes to compensate for the necessary correction for2 Journal of Biomedicine and Biotechnology
multiple testing, and are, therefore, impossible to conduct by
smaller research teams. Small laboratories can, however, rely
onDNApoolingstudieswhichcutdramaticallythecost[17].
Although the sensitivity and speciﬁcity of pooled DNA
analyses are imperfect, previous research suggests that such
analysis can oﬀer an economic alternative to individual
genotyping, although clearly, not all associated loci will be
detected. Association studies using microsatellite markers
distributed across the human genome every 100 to 150kb
were reported to have distinct advantages over SNP typing
because of the much longer extent of linkage disequilibrium
(LD)ofmicrosatellitesandtheirhigherinformativeness[18].
When an appropriate isolated population of relatively
recent origin can be studied, it might be possible to use fewer
microsatellite markers to screen the entire genome [19].
Basedonthistheory,weinvestigatedtheimmigrationhistory
of the population residing in Shandong peninsula of China.
In particular, we identiﬁed the population of the Chang Le
area as having the elements of an isolate. This area is located
inthemiddleeastofShandongpeninsulaandthepopulation
there expanded from a limited number of ancestors who
emigrated from Shan Xi Hong Dong district in 1388. We
reasoned that the 600year-long history of this population is
short enough to preserve long LD, so that some it might be
captured by only 400 microsatellite markers spaced at about
10cm throughout human genome. We admit that there is no
suﬃcient evidence that this is a homogenous population and
that our coverage of the genome is likely to be insuﬃcient.
Ideally, we would have preferred to cover the genome with
3000–6000 markers, but this was beyond our resources.
2.MaterialsandMethods
2.1. Subjects. A number of 119 unrelated SZ cases and 119
controls from Chang Le County in Shandong peninsula
of China were recruited for the ﬁrst stage of the DNA
pooling genome screen. According to the historical records
(Ming Taizu Record), the population of Shandong peninsula
in the fourteenth century was reduced dramatically due
to continuous war, natural disasters (ﬂood, plague, and
grasshoppers) and most of the villages were devastated.
Many people left the area. In contrast, no war or natural
disasters took place in Shan Xi province at that time. The
two provinces are separated by 1000-kilometer distance and
high mountains, serving as a natural barrier. To balance
the population distribution in China, the Emperor ofming
dynasty (Y.Z. Zhu) initiated two massive immigration waves
from Shan Xi to Shandong peninsula from 1388 to 1389
in order to repopulate that region. It appears that the
present-day populations of Shandong peninsula are mostly
oﬀspring expanded from diﬀerent groups of limited number
of ancestors that settled there 600years ago. So, we expect a
high degree of homogeneity in the genetic structure of this
population, compared with the outbred populations formed
intherecent50yearsinmanyotherpartsofChina,especially
in the big cities. The average age of the cases was 33.98 ±
11.99,andthemale/femaleratiowas1.05(61/58);theaverage
ageofthecontrolswas22.14±5.59,andthemale/femaleratio
was1.05(61/58),thediﬀerenceinaverageageofthecasesand
controls is signiﬁcant.
Other two groups of SZ cases and controls from Jinan
and Zichuan area were recruited giving a total of 309
cases and 309 controls for thesecond stage of the study.
All SZ cases were from inpatient departments of local
psychiatric hospitals. The average age was 27.52 ±10.84, the
male/female ratio was 1.73(196/113). All controls were from
the corresponding local blood transfusion centers that were
geographically matched to the three psychiatric hospitals.
Controls were not screened for mental illness. The average
age of controls was 34.21 ± 22.22 and the male/female
ratio was 1.83(200/109). All cases and controls are Han
Chinese.DiagnosesweremadeaccordingtoDSM-IVcriteria
[20] by at least two experienced psychiatrists, on the basis
of empirical diagnostic interviews and review of medical
records. Written consent was obtained from all subjects and
this study was approved by the Ethics Committee of the
Institute of Basic Medicine of Shandong Academy of Medical
Sciences.
2.2. DNA Pools Construction. Genomic DNA was extracted
from peripheral venous blood by a modiﬁed phenol–
chloroform method. The concentration was measured twice
on a DU-530 Life science UV/V spectrophotometer (BECK-
MAN). Samples showing > 10% diﬀerence were measured
againandweusedthemeanofthethreemeasurements.DNA
samples were diluted to 20ng/µL working concentrations,
and two DNA pools from SZ cases and controls were
constructed, respectively, by adding up 10µLo fe a c hs a m p l e .
2.3. Genotyping. We used microsatellite markers from the
ABI PRISM Linkage Mapping Set MD-10 (Applied Biosys-
tems, Foster City, Calif, USA) comprising 400 markers with
an average spacing of 10cm. Polymerase Chain Reaction
(PCR) in a 15µLv o l u m ew a sp e r f o r m e dw i t h2 0 n go f
genomic DNA, 1.5mM MgCI2, 10x reaction buﬀer, 0.2mM
of each dNTP, 0.3µMo fe a c hp r i m e r ,a n d1 Uo fT a q
polymerase. Ampliﬁcation was performed on a Gene Amp
9700 thermocycler (Applied Biosystems) with the following
parameters: 95
◦C for 12minutes initial denaturation, fol-
lowedby94
◦C15seconds,55
◦C15seconds,72
◦C30seconds,
10 cycles; then 89
◦C 15seconds, 55
◦C 15seconds, 72
◦C
30 seconds, 20 cycles, then 72
◦C 10minutes, and 4◦C
hold. Electrophoresis was carried out on ABI PRISM 3100-
Avant Genetic Analyzer, by mixing up to 9 PCR products
simultaneously, which had no overlap of products of the
same size range labelled with the same dye. Genotyping
was performed with GeneMapper 3.5 software (Applied
Biosystems).
SNPs for ﬁne mapping were selected from the HapMap
database (www.hapmap.org), ensuring that they are poly-
morphic in the Chinese population (CHB). LD blocks were
determined with the criteria R2 > 0.80 and minimum MAF
2%,usingHAPLOVIEWver.3.2software[21].Haplotypetag
SNPs (htSNPs) were deﬁned as those capturing 90% of the
haplotype diversity within each LD block with no exclusion
criterion ofminimumminor allelefrequency.FourteenSNPsJournal of Biomedicine and Biotechnology 3
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Figure 1: Linkage disequilibrium in JARID2 and DTNBP1 in a homogenous population in Shandong peninsula of China. The AT haplotype
in JARID2 (block1) more in cases than in controls (Frequency = 0.667, Case control ratios = 108.0:6 8 .0,125.6:4 8 .4; X
2 = 4.622,P =
.0316), allelic and genotypic association also observed. This samples was from an isolated population with about 600years history of
immigration in the middle east of Shandong peninsular of China.
were selected around DTNPB1 and JARID2 (Table 2).
Thirteen of those were genotyped using the Sequenom
Mass ARRAY system as per the manufacturer’s instructions
with either hME or iplex chemistries. SNP rs4715984 was
genotyped with allele-speciﬁc PCR using the Ampliﬂuor
system [22, 23], as it would not ﬁt on a Sequenom panel.
All assays used to type the full association sample were
optimized initially by genotyping DNA from the 30CEPH
parent–oﬀspring trios used in the international HapMap
project. All genotypes were called blind to sample identity
and aﬀected status.
2.4. Statistical Analysis. The predicted allele frequencies of
microsatellites between cases and controls in DNA pools
were ﬁrst estimated by dividing each allele peak height
obtained by the GeneMapper v3.5 software with the sum of4 Journal of Biomedicine and Biotechnology
all peak heights of that marker. This ratio was converted into
allele counts and the statistical signiﬁcance was calculated
with CLUMP [24] which can analyze multiallelic markers.
The analysis of individual genotyping of D6S289 was also
performed by CLUMP.
Tests of allelic, haplotype association, and Hardy Wein-
berg equilibrium were performed with HAPLOVIEW3.32
[21]; Genotypic and allelic association analyses were per-
formed with PLINK [25]. Haplotype association of the
microsatellite marker D6S289 and SNPs was performed with
UNPHASED [26].
3. Results
All 400microsatellites were genotyped, some after repeated
PCR and/or electrophoresis. A P value of <.05 produced
by CLUMP was set as a cut-oﬀ point for follow-up with
individual genotyping. Markers meeting this standard were
repeated in both PCR and electrophoresis, and the number
of replications varied from 2 to 5 times depending on
the quality of the genotypes achieved. A total of 126loci
were repeated and only three markers remained signiﬁcant:
D4S403, D6S276, and D6S289.
D6S289 is located on chromosome 6p23 within the
linkage locus for schizophrenia (SCZD3). It lies within
JARID2 and immediately adjacent to DTNBP1,as t r o n g
candidate gene for SZ. Therefore, we chose it as a priority
for individual genotyping, which conﬁrmed the predicted
association: X2 = 17.89, P = .047. A total of eleven alleles
were observed, and three alleles (209, 211 and 213) were
m o r ec o m m o ni nc a s e st h a ni nc o n t r o l s( T a b l e1).
SNP genotyping was performed on the samples included
in the pool, and in additional cases and controls, giving a
total of 309 casesand 309 controls. Genotypes of the 14 SNPs
located in JARID2 and DTNBP1 in the same 90CEU DNA
samples used in the HapMap Project were 100% concordant
with HapMap data. However 13 of the 14 SNPs were in
Hardy Weinberg equilibrium, with rs4715984 showing HW
P value of .001. No signiﬁcant association with illness was
observed for any single marker by allele or genotype in
the whole cohort of 309 cases and 309 controls (data not
shown).
Then we tested separately the association in the three
geographical samples. In the sample from Chang Le (89
cases and 88 controls available from the 119 pooling cohort),
two SNPs, rs2235258 and rs9654600 (both 3’ of JARID2)
showed allelic (Table 2), genotypic (rs2235258, X2 = 7.029,
P = .02976; rs9654600, X2 = 4.006, P = .04533 DOM)
and haplotypic association; Three of the eleven observed
haplotypes between D6S289 with rs2235258 or rs9654600
were more common in cases than in controls: 211bp-A-T
(6%incases,0%inc ontr ols,X 2 = 10.56,P = .0011);211bp-
G-T (10.3% in cases, 3% in controls, X2 = 9.42, P = .0021);
213bp-G-A (9.5% in cases, 1.8% in controls, X2 = 5.52, P =
.018); haplotype 207bp-A-T was more common in controls
(11.9% in cases, 23.1% in controls, X2 = 7.9, P = .0049). No
association was detected in samples from Ji Nan and Zi Cuan
area. The SNPs genotyped across the two genes are in a high
LD with each other (Figure 1).
4. Discussion
In this paper, we ﬁrst performed a DNA pooling study with
119 SZ cases and 119 healthy controls from an isolated
population in China. We covered the entire genome with
400microsatellite markers, assuming that in an isolated
population the LD would cover larger distances and some
association signals can be detected with this space cover-
age. The extent of linkage disequilibrium (LD) in general
populations is unlikely to extend for more than 1Mb [27].
Therefore, genome screens to map disease loci by case
control design usually require at least 3000–6000 highly
polymorphic, evenly spaced microsatellite markers. How-
ever, when an appropriate isolated population of relatively
recent origin is available for association mapping of disease,
a few hundred markers could be suﬃcient to scan the whole
genome, if it can be assumed that linkage disequilibrium
extends to ≥ 10Mb [19]. Based on this view, we investigated
the immigration history of the population in Shandong
peninsula, and chose samples from three geographical areas.
From the pooling study, we identiﬁed a positive signal
on chromosome 6, near DTNPB1, and conﬁrmed the
association with individual genotyping of the microsatellite
marker, X2 = 17.89, P = .047. We then saturated the region
with 14 SNPs and typed them individually in an extended
sample of 309 cases and 309 controls (including 89 cases
and 88 controls in the pools). SNPs genotyping showed
association with two of them in the original sample included
in the pool. Allelic association was observed with rs2235258
and rs9654600 of P = .0087 and P = .046, respectively.
The association was not replicated in the additional samples
from other regions, LD between the microsatellite marker
and SNPs in the region extended up to 8Mb in the relatively
isolated population of Chang Le, although we admit that
we do not know the corresponding extent of LD in the
other Chinese samples, as they were not genotyped for the
microsatellite. The maintenance of homogeneity in genetic
structure in the Chang Le population is mainly due to the
economy, which has long been dominated by agriculture.
According to the “Ming Tai Zu Record,” this population
expanded from a limited number of ancestors who were
resettled from the Shanxi province by Emperor YZ Zhu
during theming dynasty (AD1388). No further immigration
happened in the following 600years. Relatively isolated
populations have produced some promising ﬁndings in
psychiatric genetics in the past [28], such as for the genes
NRG1 [29]a n dD A O A[ 30].
One weakness of the current study is that only 89 cases
from Chang Le are available for the SNP genotyping. Such
a small sample size could lead to a false positive ﬁnding
(type 1 error). However, the possibility of type 1 error is
reduced because our analysis was carried out on an isolated
population, reducing genetic heterogeneity. In addition, the
association ﬁndings were based on an analysis of a gene
targeted by our hypothesis-free genome wide linkage study, a
region previously linked to schizophrenia by many groups.
The association was not present in additional samples
from the same peninsula. This could indicate that the genetic
structure of the population in Shandong peninsula is notJournal of Biomedicine and Biotechnology 5
Table 1:AllelefrequenciesofgenotypingofD6S289in119SZcasesand119controlsfromahomogenouspopulationinShandongpeninsula
of China. Normal chi-square (T1) = 17.89, P = .047). This was reached 4657 times in 100 000 simulations by clump analysis.
Alleles (bp) 207 209 211 213 215 217 219 221 223 225 227
Case 24 20 20 18 62 64 22 6 1 0 1
Control 39 17 7 14 65 61 19 8 5 3 0
Table 2: Association Analysis of SNPs within JARID2 and DTNBP1 from a homogenous population in Shandong peninsula of China. 177
individuals with nonmissing phenotypes, 89 cases, 88 controls and 0 missing, 87 males, 90 females, 12 of 177 individuals removed for low
genotyping (MIND > 0.1), Total genotyping rate in remaining individuals is 0.933333.
SNP A1 F AF UA 2 C H I S Q P OR
jarid2rs2235258 3 0.3851 0.25 1 6.881 .00871 1.879
jarid2rs9654600 1 0.2644 0.1731 4 3.979 .04607 1.717
jarid2rs1474587 4 0.08046 0.05769 2 0.6576 .4174 1.429
jarid2rs13198512 4 0.1322 0.2051 2 3.151 .07587 0.5902
dtnbp1rs742106 3 0.3908 0.3846 1 0.01327 .9083 1.026
dtnbp1rs16876575 4 0.1092 0.141 2 0.7659 .3815 0.7466
dtnbp1rs9296977 2 0.09195 0.0641 4 0.8791 .3484 1.478
dtnbp1rs4712253 4 0.3563 0.3718 2 0.0851 .705 0.9353
dtnbp1rs4715984 1 0.02299 0.03205 2 0.2547 .6138 0.7106
dtnbp1rs9358063 4 0.1092 0.08974 2 0.3458 .5565 1.243
dtnbp1rs2619533 1 0.08621 0.05769 4 0.9917 .3193 1.541
dtnbp1rs4715986 4 0.2701 0.2436 1 0.3026 .5822 1.149
dtnbp1rs2619542 2 0.2759 0.2436 4 0.4446 .5049 1.183
dtnbp1rs9476886 4 0.3391 0.3205 2 0.1282 .7203 1.088
uniform, and the relatively homogenous population might
be only restricted to a certain range of geographic area
(100–150km according to this study). Our ﬁndings suggest
that the power to detect association is not merely related
to enlargement of the sample size, but more importantly,
to the genetic structure in the samples. Therefore, using a
heterogeneous population increases the chance of producing
a false negative result (type II error).
JARID2 (jumonji, AT rich interactive domain 2) is an
ortholog of the mouse jumonji gene, which encodes a
nuclearproteinessentialformouseembryogenesis,including
neural tube formation. Over expression of mouse jumonji
negatively regulates cell proliferation. The jumonji proteins
contain a DNA-binding domain, called an AT-rich interac-
tion domain (ARID), and share regions of similarity with
human retinoblastoma-binding protein-2 and the human
SMCXprotein.TheﬁrstreportofJARID2 asacandidategene
for 6p23-linked SZ was from the USA [31]a n do u rs t u d y
suggests that JARID2, rather than DTNBP1, is a candidate
gene for 6p22.3-linked SZ. A signiﬁcant diﬀerence in allele
distribution for a tetra nucleotide repeat polymorphism in
the JARID2 gene that aﬀects an AT-rich domain was found
in that study. In our study, for D6S289, a dinucleotide repeat
polymorphism of 11 alleles in JARID2, alleles of 209, 211,
and 213bp were more frequent in SZ cases than controls
from Chang Le area of Shandong peninsula. This association
was also present in two SNPs within the gene, rs2235258 and
rs9654600.
Straub et al. described the results of family-based associ-
ation analysis on chromosome 6p and ﬁrst reported genetic
variation in the DTNBP1 gene, encoding dysbindin, which
was associated with schizophrenia and related phenotypes
[32]. The association has been well replicated in several pop-
ulations, including Caucasian, Chinese (Shanghai, Sichuan)
and Japanese samples [33–41]. Furthermore, variation in
DTNBP1 conferring susceptibility to schizophrenia through
reduced expression has also been reported [6, 42]. However,
no disease-causing alleles have been identiﬁed so far and
some replication studies failed to provide positive results
[43–48].
Including the current one, there have been a total of
four studies on DTNBP1 in Chinese SZ samples: three of
these samples were recruited from the southern part of
Yangtze River, which is the biggest natural barrier in China
and divides the Chinese population into two parts from
an anthropological point of views. In Sichuan samples, a
single haplotype, which included rs2619538 and P1583; and
another rare haplotype, composed of P1320 and P1757,
were signiﬁcantly associated with SZ [37]. In samples from
Shanghai, only a haplotypic (TGTCA) but no allelic or
genotypic association was observed [49]. No association
was reported with SZ in families from Taiwan either [45].
Therefore,theassociationofDTNBP1withSZintheChinese
population is far from convincing. The evidence implicating
DTNBP1 as a susceptibility gene by so many investigators
could not be regarded as invalid, and the extremely close6 Journal of Biomedicine and Biotechnology
proximity of JARID2 and DTNBP1 (within 1553bp), makes
them very likely to be regulated coordinately. DTNBP1 could
be a downstream target of the JARID2 transcription factor,
or both are coordinately regulated by the same cis or trans-
acting factor [31]. The design of the SNPs genotyping was
originally fortesting the DTNBP1association in this Chinese
SZ samples, therefore, the JARID2 5’ end was not analyzed in
this study.
5. WebResources
T h eU R L sf o rd a t ap r e s e n t e dh e r e i na r ea sf o l l o w s :
(1) Online Mendelian Inheritance in Man (OMIM),
http://www.ncbi.nlm.nih.gov/Omim/ (for schizophrenia;
SCZD, schizophrenia3; SCZD3);
(2) Entrez Gene, http://www.ncbi.nlm.nih.gov/sites/
entrez?db=gene (for JARID2 and DTNBP1);
(3) UCSC, http://genome.ucsc.edu/ (for SNPs primer
design);
(4) GDB, http://www.gdb.org/ (for d6s289 primer syn-
thesis);
(5) HapMap, http://www.hapmap.org/ (for the compari-
son of SNP genotype in CEPH samples and the selection of
tag SNPs);
(6) Haploview3.32, http://www.broad.mit.edu/personal/
jcbarret/haploview/ (for the tests ofallelic, haplotypic associ-
ation and Hardy Weinberg equilibrium);
(7) Clump, http://www.smd.qmul.ac.uk/statgen/dcurtis/
software.html (For the analysis of pooled and individual
genotyping of microsatellite markers);
(8)PLINK, http://pngu.mgh.harvard.edu/purcell/plink/
(fortheanalysisofgenotypicandallelicassociationofSNPs);
(9) UNPHASED, http://www.mrc-bsu.cam.ac.uk/per-
sonal/frank/software/unphased/ (for analysis of the associa-
tion between d6s289 and all SNPs).
Acknowledgments
The authors would like to thank Dr. Lyudmila Georgieva;
Dr. Dilihan Gumus; Dr. Tim Peirce, Dr. Hywel Williams,
and Sarah Dwyer for their technical assistance. The authors
would like to thank Dr. Jan P Zhu and Dr. Zheng Weng for
assistanceincollectingthebloodsamples.Theauthorswould
like also to thank all the patients and controls participated
in this research. This work was supported by grants from
the Natural Science Foundation of Shandong Province,
China (Grants IDZ2004C10; Z2008C11), the National Nat-
ural Science Foundation of China (Grant no. 30440042;
30770780), the Medical Research Council (UK) and the
National Institute of the Neuroscience of Mental Disorders
(Grant no. MH066392).
References
[1] Gottesman II, Schizophrenia Genesis: The Origins of Madness,
W. H. Freeman, New York, NY, USA, 1991.
[2] M. J. Owen, “Genomic approaches to schizophrenia,” Clinical
Therapeutics, vol. 27, supplement 1, pp. S2–S7, 2005.
[3] G. Kirov, M. C. O’Donovan, and M. J. Owen, “Finding
schizophrenia genes,” The Journal of Clinical Investigation, vol.
115, no. 6, pp. 1440–1448, 2005.
[4] M. J. Owen, N. Craddock, and M. C. O’Donovan,
“Schizophrenia: genes at last?” Trends in Genetics, vol. 21, no.
9, pp. 518–525, 2005.
[ 5 ] S .D .D e t e r a - W a d l e i g ha n dF .J .M c M a h o n ,“ G 7 2 / G 3 0
in schizophrenia and bipolar disorder: review and meta-
analysis,” Biological Psychiatry, vol. 60, no. 2, pp. 106–114,
2006.
[6] N. J. Bray, A. Preece, N. M. Williams, et al., “Haplotypes at the
dystrobrevin binding protein 1 (DTNBP1) gene locus mediate
risk for schizophrenia through reduced DTNBP1 expression,”
Human Molecular Genetics, vol. 14, no. 14, pp. 1947–1954,
2005.
[7] D. Hall, J. A. Gogos, and M. Karayiorgou, “The contribution
of three strong candidate schizophrenia susceptibility genes
in demographically distinct populations,” Genes, Brain and
Behavior, vol. 3, no. 4, pp. 240–248, 2004.
[8] A. J. Law, B. K. Lipska, C. S. Weickert, et al., “Neuregulin 1
transcripts are diﬀerentially expressed in schizophrenia and
regulated by 5  SNPs associated with the disease,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 103, no. 17, pp. 6747–6752, 2006.
[9] P. Levitt, P. Ebert, K. Mirnics, V. L. Nimgaonkar, and D. A.
Lewis, “Making the case for a candidate vulnerability gene in
schizophrenia: convergent evidence for regulator of G-protein
signaling 4 (RGS4),” Biological Psychiatry,v o l .6 0 ,n o .6 ,p p .
534–537, 2006.
[10] R. J. Klein, C. Zeiss, E. Y. Chew, et al., “Complement factor H
polymorphism in age-related macular degeneration,” Science,
vol. 308, no. 5720, pp. 385–389, 2005.
[11] J. Marx, “Gene oﬀers insight into macular degeneration,”
Science, vol. 314, no. 5798, p. 405, 2006.
[12] E. Pennisi, “New gene found for inherited macular degenera-
tion,” Science, vol. 281, no. 5373, p. 31, 1998.
[13] R. Saxena, B. F. Voight, V. Lyssenko, et al., “Genome-wide
association analysis identiﬁes loci for type 2 diabetes and
triglyceride levels,” Science, vol. 316, no. 5829, pp. 1331–1336,
2007.
[14] W. Thomson, A. Barton, X. Ke, et al., “Rheumatoid arthritis
associationat6q23,”Nature Genetics,vol.39,no.12,pp.1431–
1433, 2007.
[15] Z. Yang, N. J. Camp, H. Sun, et al., “A variant of the
HTRA1 gene increases susceptibility to age-related macular
degeneration,” Science, vol. 314, no. 5801, pp. 992–993, 2006.
[16] E. Zeggini, M. N. Weedon, C. M. Lindgren, et al., “Replication
of genome-wide association signals in UK samples reveals risk
loci for type 2 diabetes,” Science, vol. 316, no. 5829, pp. 1336–
1341, 2007.
[17] G. Kirov, I. Nikolov, L. Georgieva, V. Moskvina, M. J. Owen,
and M. O’Donovan, “Pooled DNA genotyping on aﬀymetrix
SNP genotyping arrays,” BMC Genomics, vol. 7, no. 1, article
27, 2006.
[18] G. Tamiya, M. Shinya, T. Imanishi, et al., “Whole genome
association study of rheumatoid arthritis using 27 039
microsatellites,”HumanMolecularGenetics,vol.14,no.16,pp.
2305–2321, 2005.
[19] J. H¨ astbacka, A. de la Chapelle, I. Kaitila, P. Sistonen, A.
Weaver, and E. Lander, “Linkage disequilibrium mapping
in isolated founder populations: diastrophic dysplasia in
Finland,” Nature Genetics, vol. 2, no. 3, pp. 204–211, 1992.Journal of Biomedicine and Biotechnology 7
[20] APA, Diagnostic and Statistical Manual of Mental Disorders
DSM-IV-TR, American Psychiatric Association, Washington,
DC, USA, 4th edition, 1994.
[21] J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview:
analysis and visualization of LD and haplotype maps,” Bioin-
formatics, vol. 21, no. 2, pp. 263–265, 2005.
[22] J. R. Hawkins, Y. Khripin, A. M. Valdes, and T. A. Weaver,
“Miniaturized sealed-tube allele-speciﬁc PCR,” Human Muta-
tion, vol. 19, no. 5, pp. 543–553, 2002.
[23] M. V. Myakishev, Y. Khripin, S. Hu, and D. H. Hamer, “High-
throughput SNP genotyping by allele-speciﬁc PCR with
universal energy-transfer-labeled primers,” Genome Research,
vol. 11, no. 1, pp. 163–169, 2001.
[24] P. C. Sham and D. Curtis, “Monte Carlo tests for associations
betweendiseaseandallelesathighlypolymorphicloci,”Annals
of Human Genetics, vol. 59, no. 1, pp. 97–105, 1995.
[25] S. Purcell, B. Neale, K. Todd-Brown, et al., “PLINK: a tool set
for whole-genome association and population-based linkage
analyses,” American Journal of Human Genetics, vol. 81, no. 3,
pp. 559–575, 2007.
[26] F. Dudbridge, “Pedigree disequilibrium tests for multilocus
haplotypes,” Genetic Epidemiology, vol. 25, no. 2, pp. 115–121,
2003.
[27] E. Dawson, G. R. Abecasis, S. Bumpstead, et al., “A ﬁrst-
generation linkage disequilibrium map of human chromo-
some 22,” Nature, vol. 418, no. 6897, pp. 544–548, 2002.
[28] T. Venken and J. Del-Favero, “Chasing genes for mood dis-
orders and schizophrenia in genetically isolated populations,”
Human Mutation, vol. 28, no. 12, pp. 1156–1170, 2007.
[29] H. Stefansson, E. Sigurdsson, V. Steinthorsdottir, et al.,
“Neuregulin 1 and susceptibility to schizophrenia,” American
Journal of Human Genetics, vol. 71, no. 4, pp. 877–892, 2002.
[30] I. Chumakov, M. Blumenfeld, O. Guerassimenko, et al.,
“Genetic and physiological data implicating the new human
gene G72 and the gene for D-amino acid oxidase in
schizophrenia,”ProceedingsoftheNationalAcademyofSciences
of the United States of America, vol. 99, no. 21, pp. 13675–
13680, 2002.
[31] E. Pedrosa, K. Ye, K. A. Nolan, et al., “Positive association of
schizophrenia to JARID2 gene,” American Journal of Medical
Genetics B, vol. 144, no. 1, pp. 45–51, 2007.
[32] R. E. Straub, Y. Jiang, C. J. MacLean, et al., “Genetic variation
in the 6p22.3 Gene DTNBP1, the human ortholog of the
mouse dysbindin gene, is associated with schizophrenia,”
American Journal of Human Genetics, vol. 71, no. 2, pp. 337–
348, 2002.
[33] P. DeRosse, B. Funke, K. E. Burdick, et al., “Dysbindin
genotype and negative symptoms in schizophrenia,” American
Journal of Psychiatry, vol. 163, no. 3, pp. 532–534, 2006.
[34] B. Funke, C. T. Finn, A. M. Plocik, et al., “Association of
the DTNBP1 locus with schizophrenia in a U.S. population,”
American Journal of Human Genetics, vol. 75, no. 5, pp. 891–
898, 2004.
[35] G. Kirov, D. Ivanov, N. M. Williams, et al., “Strong evidence
for association between the dystrobrevin binding protein 1
gene (DTNBP1) and schizophrenia in 488 parent-oﬀspring
trios from Bulgaria,” Biological Psychiatry, vol. 55, no. 10, pp.
971–975, 2004.
[36] Y.Kohn,E.Danilovich,D.Filon,etal.,“Linkagedisequlibrium
in the DTNBP1 (dysbindin) gene region and on chromosome
1p36 among psychotic patients from a genetic isolate in Israel:
ﬁndings from identity by descent haplotype sharing analysis,”
American Journal of Medical Genetics B, vol. 128, no. 1, pp. 65–
70, 2004.
[37] T. Li, F. Zhang, X. Liu, et al., “Identifying potential risk
haplotypes for schizophrenia at the DTNBP1 locus in Han
Chinese and Scottish populations,” Molecular Psychiatry, vol.
10, no. 11, pp. 1037–1044, 2005.
[38] T. Numakawa, Y. Yagasaki, T. Ishimoto, et al., “Evidence of
novel neuronal functions of dysbindin, a susceptibility gene
for schizophrenia,” Human Molecular Genetics, vol. 13, no. 21,
pp. 2699–2708, 2004.
[39] S. G. Schwab, M. Knapp, S. Mondabon, et al., “Support for
association of schizophrenia with genetic variation in the
6p22.3 gene, dysbindin, in sib-pair families with linkage and
in an additional sample of triad families,” American Journal of
Human Genetics, vol. 72, no. 1, pp. 185–190, 2003.
[40] A. Van Den Bogaert, J. Schumacher, T. G. Schulze, et al.,
“The DTNBP1 (dysbindin) gene contributes to schizophrenia,
depending on family history of the disease,” American Journal
of Human Genetics, vol. 73, no. 6, pp. 1438–1443, 2003.
[41] N. M. Williams, A. Preece, D. W. Morris, et al., “Identiﬁcation
in 2 independent samples of a novel schizophrenia risk hap-
lotype of the dystrobrevin binding protein gene (DTNBP1),”
Archives of General Psychiatry, vol. 61, no. 4, pp. 336–344,
2004.
[42] C. S. Weickert, R. E. Straub, B. W. McClintock, et al., “Human
dysbindin (DTNBP1) gene expression in normal brain and
in schizophrenic prefrontal cortex and midbrain,” Archives of
General Psychiatry, vol. 61, no. 6, pp. 544–555, 2004.
[43] S. R. Datta, A. McQuillin, V. Puri, et al., “Failure to conﬁrm
allelicandhaplotypicassociationbetweenmarkersatthechro-
mosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1)
locus and schizophrenia,” Behavioral and Brain Functions, vol.
3, no. 1, article 50, 2007.
[ 4 4 ]E . - J .J o o ,K . - Y .L e e ,S .H .J e o n g ,Y . - M .A h n ,Y .J .K o o ,a n dY .
S. Kim, “The dysbindin gene (DTNBP1) and schizophrenia:
no support for an association in the Korean population,”
Neuroscience Letters, vol. 407, no. 2, pp. 101–106, 2006.
[45] C.-M. Liu, Y.-L. Liu, C. S.-J. Fann, et al., “No association
evidence between schizophrenia and dystrobrevin-binding
protein 1 (DTNBP1) in Taiwanese families,” Schizophrenia
Research, vol. 93, no. 1–3, pp. 391–398, 2007.
[46] D. W. Morris, K. A. McGhee, S. Schwaiger, et al., “No
evidence for association of the dysbindin gene [DTNBP1]
with schizophrenia in an Irish population-based study,”
Schizophrenia Research, vol. 60, no. 2-3, pp. 167–172, 2003.
[47] M. Mutsuddi, D. W. Morris, S. G. Waggoner, M. J. Daly, E. M.
Scolnick, and P. Sklar, “Analysis of high-resolution HapMap
of DTNBP1 (dysbindin) suggests no consistency between
reported common variant associations and schizophrenia,”
American Journal of Human Genetics, vol. 79, no. 5, pp. 903–
909, 2006.
[48] J. A. Turunen, J. O. Peltonen, O. P. H. Pietil¨ ainen, et al.,
“The role of DTNBP1, NRG1, and AKT1 in the genetics of
schizophrenia in Finland,” Schizophrenia Research, vol. 91, no.
1–3, pp. 27–36, 2007.
[49] J. X. Tang, J. Zhou, J. B. Fan, et al., “Family-based association
study of DTNBP1 in 6p22.3 and schizophrenia,” Molecular
Psychiatry, vol. 8, no. 8, pp. 717–718, 2003.